Simplex Trading’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275K Buy
141,100
+140,900
+70,450% +$365K ﹤0.01% 3917
2025
Q4
$358 Sell
200
-1,000
-83% -$2.19K ﹤0.01% 8201
2025
Q3
$2K Buy
+1,200
New +$1.94K ﹤0.01% 8684
2025
Q1
Sell
-276,600
Closed -$2.93M 9264
2024
Q4
$2.93M Buy
276,600
+265,900
+2,485% +$3.19M ﹤0.01% 1870
2024
Q3
$141K Buy
10,700
+3,900
+57% +$45.5K ﹤0.01% 4876
2024
Q2
$66K Hold
6,800
﹤0.01% 5792
2024
Q1
$93K Buy
6,800
+6,500
+2,167% +$105K ﹤0.01% 5664
2023
Q4
$5K Buy
+300
New +$3.68K ﹤0.01% 7882

Other funds holding NMRA

Simplex Trading's NMRA Position: Q1 2026 in Review

Simplex Trading opened a new position in Neumora Therapeutics (NMRA) in Q1 2026: 129,156 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #4021 among its holdings. This is a return to the name: Simplex Trading previously reported a position in NMRA as recently as Q3 2025.

Simplex Trading first reported a position in NMRA in Q1 2024 and has held it in 6 quarters since. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • Simplex Trading held 129,156 shares of Neumora Therapeutics worth $252K as of Q1 2026.
  • Neumora Therapeutics was a new Simplex Trading position in Q1 2026.
  • Neumora Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4021 holding.
  • Simplex Trading first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.